Why Cabot (CBT) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2247346/why-cabot-cbt-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2247346
Mar 28, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2239245/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2239245
Mar 12, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status
https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299
Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
0